Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946127 · ClinicalTrials.gov registry record
ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus
A clinical trial, sponsored by Johns Hopkins University.
- Terminated
- Registry status
- 13
- Enrollment target
NCT00946127: Clinical Trial study, sponsored by Johns Hopkins University.
NCT00946127 is a clinical trial that was terminated before completion, run by Johns Hopkins University. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00946127 was terminated before completion, sponsored by Johns Hopkins University.
- TERMINATED
- Registry status
- 13 participants
- Enrollment target
Study Summary
The purpose of this study is to test and compare the efficacy of Endoscopic Third Ventriculostomy with shunting of Cerebrospinal fluid (CSF)for treatment for patients of Normal pressure Hydrocephalus.
Interventions
- PROCEDURE Ventriculoperitoneal Shunt Placement
- PROCEDURE Endoscopic Third Ventriculostomy(ETV)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-10 |
Why NCT00946127 stopped before completion
NCT00946127 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which Ventriculoperitoneal Shunt Placement is the first listed.
NCT00946127 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00946127 about?
NCT00946127 is a clinical study titled "ETV Versus Shunt Surgery in Normal Pressure Hydrocephalus". The purpose of this study is to test and compare the efficacy of Endoscopic Third Ventriculostomy with shunting of Cerebrospinal fluid (CSF)for treatment for patients of Normal pressure Hydrocephalus.
What is the current status of trial NCT00946127?
This trial is currently terminated. The enrollment target is 13 participants. The study started on 2009-03. Estimated completion is 2011-10.
What interventions are being tested in trial NCT00946127?
The interventions under investigation include: Ventriculoperitoneal Shunt Placement (PROCEDURE), Endoscopic Third Ventriculostomy(ETV) (PROCEDURE).
Who is sponsoring clinical trial NCT00946127?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia